🚀 VC round data is live in beta, check it out!
Sysmex Valuation Multiples
Discover revenue and EBITDA valuation multiples for Sysmex and similar public comparables like Caris Life Sciences, Bruker, Getinge, Snibe and more.
Sysmex Overview
About Sysmex
Sysmex Corp manufactures and sells laboratory testing equipment and reagents. It conducts product development, manufacturing, sales, and service activities in domestic markets, while certain products are also developed, manufactured, and sold through its subsidiaries. The company operates through five reportable segments based on headquarters: Head Office Management, Americas Headquarters, EMEA Headquarters, China Headquarters, and AP Headquarters.
Founded
1968
HQ
Employees
11.4K
Website
Financials (LTM)
EV
$6B
Sysmex Financials
Sysmex reported last 12-month revenue of $3B and EBITDA of $721M.
In the same LTM period, Sysmex generated $2B in gross profit, $721M in EBITDA, and $288M in net income.
Revenue (LTM)
Sysmex P&L
In the most recent fiscal year, Sysmex reported revenue of $3B and EBITDA of $872M.
Sysmex expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $3B | XXX | $3B | XXX | XXX | XXX |
| Gross Profit | $2B | XXX | $2B | XXX | XXX | XXX |
| Gross Margin | 52% | XXX | 49% | XXX | XXX | XXX |
| EBITDA | $721M | XXX | $872M | XXX | XXX | XXX |
| EBITDA Margin | 23% | XXX | 25% | XXX | XXX | XXX |
| EBIT Margin | 14% | XXX | 17% | XXX | XXX | XXX |
| Net Profit | $288M | XXX | $368M | XXX | XXX | XXX |
| Net Margin | 9% | XXX | 11% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Sysmex Stock Performance
Sysmex has current market cap of $6B, and enterprise value of $6B.
Market Cap Evolution
Sysmex's stock price is $9.34.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $6B | $6B | 0.4% | XXX | XXX | XXX | $0.59 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialSysmex Valuation Multiples
Sysmex trades at 1.8x EV/Revenue multiple, and 8.0x EV/EBITDA.
EV / Revenue (LTM)
Sysmex Financial Valuation Multiples
As of March 11, 2026, Sysmex has market cap of $6B and EV of $6B.
Equity research analysts estimate Sysmex's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Sysmex has a P/E ratio of 20.2x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $6B | XXX | $6B | XXX | XXX | XXX |
| EV (current) | $6B | XXX | $6B | XXX | XXX | XXX |
| EV/Revenue | 1.8x | XXX | 1.7x | XXX | XXX | XXX |
| EV/EBITDA | 8.0x | XXX | 6.6x | XXX | XXX | XXX |
| EV/EBIT | 12.7x | XXX | 9.6x | XXX | XXX | XXX |
| EV/Gross Profit | 3.5x | XXX | 3.4x | XXX | XXX | XXX |
| P/E | 20.2x | XXX | 15.8x | XXX | XXX | XXX |
| EV/FCF | 17.3x | XXX | 23.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Sysmex Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Sysmex Margins & Growth Rates
Sysmex's revenue in the last 12 month grew by 7%.
Sysmex's revenue per employee in the last FY averaged $0.3M.
Sysmex's rule of 40 is 29% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Sysmex's rule of X is 39% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Sysmex Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 7% | XXX | (8%) | XXX | XXX | XXX |
| EBITDA Margin | 23% | XXX | 25% | XXX | XXX | XXX |
| EBITDA Growth | 5% | XXX | (18%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 29% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 39% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.3M | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 27% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 6% | XXX | 6% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 33% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Sysmex Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Caris Life Sciences | XXX | XXX | XXX | XXX | XXX | XXX |
| Bruker | XXX | XXX | XXX | XXX | XXX | XXX |
| Getinge | XXX | XXX | XXX | XXX | XXX | XXX |
| Snibe | XXX | XXX | XXX | XXX | XXX | XXX |
| Asahi Intecc | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Sysmex M&A Activity
Sysmex acquired XXX companies to date.
Last acquisition by Sysmex was on XXXXXXXX, XXXXX. Sysmex acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Sysmex
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialSysmex Investment Activity
Sysmex invested in XXX companies to date.
Sysmex made its latest investment on XXXXXXXX, XXXXX. Sysmex invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Sysmex
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Sysmex
| When was Sysmex founded? | Sysmex was founded in 1968. |
| Where is Sysmex headquartered? | Sysmex is headquartered in Japan. |
| How many employees does Sysmex have? | As of today, Sysmex has over 11K employees. |
| Who is the CEO of Sysmex? | Sysmex's CEO is Hisashi Ietsugu. |
| Is Sysmex publicly listed? | Yes, Sysmex is a public company listed on Tokyo Stock Exchange. |
| What is the stock symbol of Sysmex? | Sysmex trades under 6869 ticker. |
| When did Sysmex go public? | Sysmex went public in 1996. |
| Who are competitors of Sysmex? | Sysmex main competitors are Caris Life Sciences, Bruker, Getinge, Snibe. |
| What is the current market cap of Sysmex? | Sysmex's current market cap is $6B. |
| What is the current revenue of Sysmex? | Sysmex's last 12 months revenue is $3B. |
| What is the current revenue growth of Sysmex? | Sysmex revenue growth (NTM/LTM) is 7%. |
| What is the current EV/Revenue multiple of Sysmex? | Current revenue multiple of Sysmex is 1.8x. |
| Is Sysmex profitable? | Yes, Sysmex is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Sysmex? | Sysmex's last 12 months EBITDA is $721M. |
| What is Sysmex's EBITDA margin? | Sysmex's last 12 months EBITDA margin is 23%. |
| What is the current EV/EBITDA multiple of Sysmex? | Current EBITDA multiple of Sysmex is 8.0x. |
| What is the current FCF of Sysmex? | Sysmex's last 12 months FCF is $334M. |
| What is Sysmex's FCF margin? | Sysmex's last 12 months FCF margin is 10%. |
| What is the current EV/FCF multiple of Sysmex? | Current FCF multiple of Sysmex is 17.3x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.